Best American College Of Cardiology Podcasts (2024)

1
JACC Edge Podcast - Cardiology of Aging 18:14

1h ago18:14

18:14

Pratik Doshi, MD, MS, and Daniel Forman MD, FACC, explore the challenges of geriatric cardiology and the critical importance of distinguishing between chronological and biological age in treating older adults. They highlight how geroscience is revolutionizing heart care, with in-depth discussions on topics like inflammation, frailty, and polypharma…

1
JACC: Cardiovascular Interventions - Comparison of Patient Outcomes Between Leadless vs Transvenous Pacemakers Following Transcatheter Aortic Valve Replacement 6:36

3d ago6:36

6:36

Mirza Umair Khalid, MD, social media editor of JACC: Cardiovascular Interventions, and Toshiki Kuno, MD, PhD, discuss a recently published original research paper examining the comparison of outcomes between leadless (micra) and transvenous pacemakers after TAVR.

1
JACC: Cardiovascular Interventions: Contemporary Trends and Outcomes of Intravascular Lithotripsy in Percutaneous Coronary Intervention: Insights From BMC2 6:39

1h ago6:39

6:39

Mirza Umair Khalid, MD, social media editor of JACC: Cardiovascular Interventions, and Devraj Sukul, MD, MSc, discuss a recently published original research paper assessing the contemporary trends and outcomes of IVL versus atherectomy (rotational & orbital) in PCI.

1
JACC: Asia Pulse - Pericardial Disease in Asia 18:41

2h ago18:41

18:41

Mohamed Al Kazaz, MD, describes pericardial disease, incidence of TB associated pericarditis in Asia, and approaches in different healthcare settings. Moderated by Neeja Patel, MD.

1
JACC: CardioOncology - Echocardiography-Guided Radiofrequency Ablation for Cardiac Tumors 2:27

2h ago2:27

2:27

In this podcast, Dr. Tim Markmann discusses a groundbreaking method for treating cardiac tumors using echocardiography-guided transapical radiofrequency ablation. This innovative approach from Dr. Liwen Liu and his team, which involves delivering thermal energy to the tumor via a percutaneous needle, shows promising results in reducing tumor size a…

1
JACC: CardioOncology - Deep Inspiration Breath Hold in Left-Sided Breast Radiotherapy: A Balance Between Side- Effects and Costs 3:51

2h ago3:51

3:51

In this podcast, Dr. Fleure Gallant and Dr. Reshma Jagsi discuss a pivotal study by Busschaert et al. on the cost-effectiveness of Deep Inspiration Breath Hold (DIBH) in left-sided breast cancer radiotherapy. They highlight how DIBH significantly reduces heart radiation dose and cardiac events, while also noting its higher costs and impact on clini…

1
JACC: CardioOncology - August 2024 Issue Summary 19:56

2h ago19:56

19:56

Audio Summary of the August Issue with Introduction by Dr. Bonnie Ky

1
JACC: CardioOncology - Atrial Fibrillation as a Prognostic Factor for All-Cause Mortality in Patients With Transthyretin Amyloid Cardiomyopathy 5:10

2h ago5:10

5:10

In this podcast, Dr. Nowell Fine discusses a study on atrial fibrillation as a prognostic factor in patients with transthyretin amyloidosis cardiomyopathy, highlighting its high prevalence but limited prognostic significance. The research, part of the TTR ACT trial, underscores the need for ongoing investigation into optimal management strategies f…

1
JACC: Asia Pulse - Valvular Disease in Asia 21:07

2h ago21:07

21:07

Mohamed Al Kazaz, MD, shares insights into valvular disease in Asia, epidemiology of rheumatic heart disease, and lifelong management strategies. Moderated by Neeja Patel, MD.

1
JACC: CardioOncology - Cardiac Substructure Radiation Dose and Associations with Tachyarrhythmia and Bradyarrhythmia After Lung Cancer Radiotherapy 2:37

2h ago2:37

2:37

In this podcast, Gerard Walls reviews a pivotal study led by Dr. Katelyn Atkins on radiation-induced arrhythmias in patients with locally advanced non-small cell lung cancer. The research provides a groundbreaking analysis of how radiation doses impact various types of arrhythmias, offering new insights for predicting and mitigating these common ca…

1
JACC: CardioOncology - Predictive Performance of Cardiovascular Risk Scores in Cancer Survivors from the UK Biobank 3:26

10h ago3:26

3:26

In this podcast, Dr. Katrina Poppe reviews a study by Celeste McCracken and Dr. Zahra Raisi-Estabragh that evaluates the effectiveness of cardiovascular risk scores in cancer survivors using UK Biobank data. The research reveals that standard risk scores often underestimate cardiovascular risk in cancer survivors, particularly those with Hodgkin's …

1
JACC: CardioOncology - Baseline Cardiac Parameters as Biomarkers of Radiation Cardiotoxicity in Lung Cancer: An NI-HEART Analysis 2:42

2h ago2:42

2:42

In this podcast, Katelyn Atkins discusses a study led by Dr. Gerard Walls from Queens University, Belfast, which investigates cardiac volumetric parameters from radiation planning CTs to predict major adverse cardiac events in patients with non-small cell lung cancer. The research highlights how baseline cardiac volumes, especially the left atrium …

1
Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity Revascularization 9:13

2h ago9:13

9:13

Dr. Valentin Fuster discusses a study on the effects of low-dose rivaroxaban combined with aspirin in fragile patients after lower extremity revascularization, focusing on the balance between efficacy and safety. It highlights that while frailty increases the risk of adverse outcomes, rivaroxaban reduces ischemic events but also raises bleeding ris…

1
JACC - August 27, 2024 Issue Summary 23:12

2h ago23:12

23:12

In this episode, Dr. Valentin Fuster covers four original papers focusing on cardiovascular disease. Highlights include the effectiveness of semaglutide in reducing weight and improving heart failure symptoms, long-lasting effects of OPASAN on lipoprotein(a) levels, the impact of low-dose rivaroxaban plus aspirin on fragile patients post-revascular…

1
The Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering: OCEAN(a)-DOSE Extension Period Results 11:12

4d ago11:12

11:12

In this episode, Dr. Valentin Fuster explores findings from the Phase 2 OCEAN-LDO trial assessing the off-treatment effects of the RNA-based drug alpcisiran on lipoprotein(a) [Lp(a)] levels. The study found that high doses of alpcisiran reduced Lp(a) levels by up to 95% during treatment, with a sustained reduction of 27-76% persisting up to 96 week…

1
Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials 10:16

2h ago10:16

10:16

Dr. Valentin Fuster discusses a study on the efficacy of semaglutide for treating obesity-related heart failure with preserved ejection fraction, highlighting that the drug significantly reduced body weight and improved heart failure symptoms in both men and women. Notably, women experienced greater weight loss than men, but this did not translate …

1
Treatment of Transcatheter Aortic Valve Thrombosis: JACC Review Topic of the Week 9:07

1d ago9:07

9:07

Dr. Valentin Fuster discusses the treatment and diagnosis of transcatheter aortic valve thrombosis, focusing on its manifestations, diagnostic techniques using multi-slice computed tomography, and a proposed treatment algorithm. It highlights the difference between subclinical and clinical thrombosis and provides a detailed approach to managing bot…

1
Deep Learning-Based Electrocardiogram Analysis Predicts Biventricular Dysfunction and Dilation in Congenital Heart Disease 11:27

2h ago11:27

11:27

Dr. Valentin Fuster evaluates a deep learning model designed to predict left and right ventricular dysfunction and dilation in congenital heart disease patients using ECG and CMR data. The research demonstrated that AI ECG can reliably identify significant cardiovascular issues, though future work should focus on refining thresholds and validating …

1
Structural Cardiac Interventions in Patients with Heart Failure: JACC Scientific Statement 40:38

2h ago40:38

40:38

In this episode, Dr. Valentin Fuster provides an overview of a scientific statement on structural cardiac interventions in heart failure. It details advances in percutaneous therapies for ventricular reshaping, valvular heart disease interventions, and tricuspid valve issues, while also highlighting gaps in current treatments and areas for future r…